- Abstract
- 10.1016/j.euroneuro.2019.09.529
P.523 Use of psychoactive drugs in paediatric population in Catalonia
- Dec 01, 2019
- European Neuropsychopharmacology
- M Fradera + 7 more +7
P.523 Use of psychoactive drugs in paediatric population in Catalonia
Identification of drug-target interactions via multiple information integration
P.523 Use of psychoactive drugs in paediatric population in Catalonia
P.523 Use of psychoactive drugs in paediatric population in Catalonia
DTI-HETA: prediction of drug-target interactions based on GCN and GAT on heterogeneous graph.
Drug-target interaction (DTI) prediction plays an important role in drug repositioning, drug discovery and drug design. However, due to the large size of the chemical and genomic spaces and the complex interactions between drugs and targets, experimental identification of DTIs is costly and time-consuming. In recent years, the emerging graph neural network (GNN) has been applied to DTI prediction because DTIs can be represented effectively using graphs. However, some of these methods are only based on homogeneous graphs, and some consist of two decoupled steps that cannot be trained jointly. To further explore GNN-based DTI prediction by integrating heterogeneous graph information, this study regards DTI prediction as a link prediction problem and proposes an end-to-end model based on HETerogeneous graph with Attention mechanism (DTI-HETA). In this model, a heterogeneous graph is first constructed based on the drug-drug and target-target similarity matrices and the DTI matrix. Then, the graph convolutional neural network is utilized to obtain the embedded representation of the drugs and targets. To highlight the contribution of different neighborhood nodes to the central node in aggregating the graph convolution information, a graph attention mechanism is introduced into the node embedding process. Afterward, an inner product decoder is applied to predict DTIs. To evaluate the performance of DTI-HETA, experiments are conducted on two datasets. The experimental results show that our model is superior to the state-of-the-art methods. Also, the identification of novel DTIs indicates that DTI-HETA can serve as a powerful tool for integrating heterogeneous graph information to predict DTIs.
Read moreA Machine Learning Approach for Drug-target Interaction Prediction using Wrapper Feature Selection and Class Balancing.
Drug-Target interaction (DTI) plays a crucial role in drug discovery, drug repositioning and understanding the drug side effects which helps to identify new therapeutic profiles for various diseases. However, the exponential growth in the genomic and drugs data makes it difficult to identify the new associations between drugs and targets. Therefore, we use computational methods as it helps in accelerating the DTI identification process. Usually, available data driven sources consisting of known DTI is used to train the classifier to predict the new DTIs. Such datasets often face the problem of class imbalance. Therefore, in this study we address two challenges faced by such datasets, i. e., class imbalance and high dimensionality to develop a predictive model for DTI prediction. The study is carried out on four protein classes namely Enzyme, Ion Channel, G Protein-Coupled Receptor (GPCR) and Nuclear Receptor. We encoded the target protein sequence using the dipeptide composition and drug with a molecular descriptor. A machine learning approach is employed to predict the DTI using wrapper feature selection and synthetic minority oversampling technique (SMOTE). The ensemble approach achieved at the best an accuracy of 95.9 %, 93.4 %, 90.8 % and 90.6 % and 96.3 %, 92.8 %, 90.1 %, and 90.2 % of precision on Enzyme, Ion Channel, GPCR and Nuclear Receptor datasets, respectively, when evaluated excluding SMOTE samples with 10-fold cross validation. Furthermore, our method could predict new drug-target interactions not contained in training dataset. Selected features using wrapper feature selection may be important to understand the DTI for the protein categories under this study. Based on our evaluation, the proposed method can be used for understanding and identifying new drug-target interactions. We provide the readers with a standalone package available at https://github.com/shwetagithub1/predDTI which will be able to provide the DTI predictions to user for new query DTI pairs.
Read moreDrug-target interaction prediction: databases, web servers and computational models.
Identification of drug-target interactions is an important process in drug discovery. Although high-throughput screening and other biological assays are becoming available, experimental methods for drug-target interaction identification remain to be extremely costly, time-consuming and challenging even nowadays. Therefore, various computational models have been developed to predict potential drug-target associations on a large scale. In this review, databases and web servers involved in drug-target identification and drug discovery are summarized. In addition, we mainly introduced some state-of-the-art computational models for drug-target interactions prediction, including network-based method, machine learning-based method and so on. Specially, for the machine learning-based method, much attention was paid to supervised and semi-supervised models, which have essential difference in the adoption of negative samples. Although significant improvements for drug-target interaction prediction have been obtained by many effective computational models, both network-based and machine learning-based methods have their disadvantages, respectively. Furthermore, we discuss the future directions of the network-based drug discovery and network approach for personalized drug discovery based on personalized medicine, genome sequencing, tumor clone-based network and cancer hallmark-based network. Finally, we discussed the new evaluation validation framework and the formulation of drug-target interactions prediction problem by more realistic regression formulation based on quantitative bioactivity data.
Read morePredicting Drug-Target Interaction (DTI) based on Machine Learning with Lasso Dimensionality Reduction and SMOTE from Protein Sequence and Drug Fingerprint
The identification of Drug-Target Interaction (DTI) is an important process in pharmaceutical scientific research to develop new therapeutic agents for diseases. However, experimental methods involving identification of DTIs are time-consuming, expensive, and challenging. Computational methods that can accurately predict DTI pairs are of great interest because they can significantly reduce time and resources in drug discovery and research. This study presents a machine-learning-based model named, kNN-DTIPred, for DTI prediction that addresses two common problems of datasets: high-dimensionality and class imbalance. First, target protein feature vectors are extracted using Pseudo-Position Specific Scoring Matrix (PsePSSM). Using OpenBabel software, drug compounds are represented using FP2 Molecular Fingerprint. Lasso Dimensionality Reduction is then used to obtain only the most discriminating features while SMOTE is applied for class balancing. Five machine learning models were compared on 4 datasets. The best model was obtained by k-Nearest Neighbors classifier with overall prediction accuracy 98.23%, 94.77%, 95.07%, and 93.09% for enzymes, ion channel, G protein-coupled receptors and nuclear receptor datasets respectively. The area under the curve reached 97.05%, 95.95%, 94.89%, and 94.29%, respectively for the datasets mentioned. Additionally, our results showed that Lasso Dimensionality Reduction and SMOTE have significantly improved the predictive performance. This study has demonstrated that the proposed kNN-DTIPred model is highly accurate and effective in predicting drug-target pairs which can accelerate the DTI identification process by limiting the search space to be investigated in laboratory experiments.
Read moreA Sparse Feature Extraction Method with Elastic Net for Drug-Target Interaction Identification
The identification of drug-target interactions (DTIs) plays a crucial role in drug discovery. However, the traditional high-throughput techniques based on clinical trials are costly, cumbersome, and time-consuming for identifying DTIs. Hence, new intelligent computational methods are urgently needed to surmount these defects in predicting DTIs. In this paper, we propose a novel computational method that combines position-specific scoring matrix (PSSM), elastic net based sparse features extraction, and rotation forest (RF) classifier. Specifically, we converted each protein primary sequence into PSSM, which contains biological evolutionary information. Then we extract the hidden sparse feature descriptors in PSSM by elastic net based sparse feature extraction method (ESFE). After that, we fuse them with the features of drug, which are represented by molecular fingerprints. Finally, rotation forest classifier works on detecting the potential drug-target interactions. When performing the proposed method by the experiments of fivefold cross validation (CV) on enzyme, ion channel, G protein-coupled receptors (GPCRs), and nuclear receptor datasets, this method achieves average accuracies of 90.32%, 88.91%, 80.65%, and 79.73%, respectively. We also compared the proposed model with the state-of-the-art support vector machine (SVM) classifier and other effective methods on the same datasets. The comparison results distinctly indicate that the proposed model possesses the efficient and robust ability to predict DTIs. We expect that the new model will be able to take effects on predicting massive DTIs.
Read moreArtificial intelligence streamlines scientific discovery of drug-target interactions.
Drug discovery is a complicated process through which new therapeutics are identified to prevent and treat specific diseases. Identification of drug-target interactions (DTIs) stands as a pivotal aspect within the realm of drug discovery and development. The traditional process of drug discovery, especially identification of DTIs, is marked by its high costs of experimental assays and low success rates. Computational methods have emerged as indispensable tools, especially those employing artificial intelligence (AI) methods, which could streamline the process, thereby reducing costs and time consumption and potentially increasing success rates. In this review, we focus on the application of AI techniques in DTI prediction. Specifically, we commence with a comprehensive overview of drug discovery and development, along with systematic prediction and validation of DTIs. We proceed to highlight the prominent databases and toolkits used in developing AI methods for DTI prediction, as well as with methodologies for evaluating their efficacy. We further extend the exploration into three primary types of state-of-the-art AI methods used in DTI prediction, including classical machine learning, deep learning and network-based methods. Finally, we summarize the key findings and outline the current challenges and future directions that AI methods face in scientific drug discovery and development. LINKED ARTICLES: This article is part of a themed issue Network Medicine and Systems Pharmacology. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v183.8/issuetoc.
Read moreEA-based hyperparameter optimization of hybrid deep learning models for effective drug-target interactions prediction
EA-based hyperparameter optimization of hybrid deep learning models for effective drug-target interactions prediction
EFMSDTI: Drug-target interaction prediction based on an efficient fusion of multi-source data
Accurate identification of Drug Target Interactions (DTIs) is of great significance for understanding the mechanism of drug treatment and discovering new drugs for disease treatment. Currently, computational methods of DTIs prediction that combine drug and target multi-source data can effectively reduce the cost and time of drug development. However, in multi-source data processing, the contribution of different source data to DTIs is often not considered. Therefore, how to make full use of the contribution of different source data to predict DTIs for efficient fusion is the key to improving the prediction accuracy of DTIs. In this paper, considering the contribution of different source data to DTIs prediction, a DTIs prediction approach based on an effective fusion of drug and target multi-source data is proposed, named EFMSDTI. EFMSDTI first builds 15 similarity networks based on multi-source information networks classified as topological and semantic graphs of drugs and targets according to their biological characteristics. Then, the multi-networks are fused by selective and entropy weighting based on similarity network fusion (SNF) according to their contribution to DTIs prediction. The deep neural networks model learns the embedding of low-dimensional vectors of drugs and targets. Finally, the LightGBM algorithm based on Gradient Boosting Decision Tree (GBDT) is used to complete DTIs prediction. Experimental results show that EFMSDTI has better performance (AUROC and AUPR are 0.982) than several state-of-the-art algorithms. Also, it has a good effect on analyzing the top 1000 prediction results, while 990 of the first 1000DTIs were confirmed. Code and data are available at https://github.com/meng-jie/EFMSDTI.
Read moreDTIFS: A Novel Computational Approach for Predicting Drug-Target Interactions from Drug Structure and Protein Sequence
Identification and prediction of Drug-Target Interactions (DTIs) is the basis for screening drug candidates, which plays a vital role in the development of innovative drugs. However, due to the time-consuming and high cost constraints of biological experimental methods, traditional drug target identification technologies are often difficult to develop on a large scale. Therefore, in silico methods are urgently needed to predict drug-target interactions in a genome-wide manner. In this article, we design a novel in silico approach, named DTIFS to predict the DTIs by combining Feature weighted Rotation Forest (FwRF) classifier with protein amino acids information. This model has two outstanding advantages: a) using the fusion data of protein sequence and drug molecular fingerprint, which can fully carry information; b) using the classifier with feature selection ability, which can effectively remove noise information and improve prediction performance. More specifically, we first use Position-Specific Score Matrix (PSSM) to numerically convert protein sequences and utilize Pseudo Position-Specific Score Matrix (PsePSSM) to extract their features. Then a unified digital descriptor is formed by combining molecular fingerprints representing drug information. Finally, the FwRF is applied to implement on Enzyme, Ion Channel, GPCR, and Nuclear Receptor datasets. The results of the 5-fold CV experiment show that the prediction accuracy of this approach reaches 91.68%, 88.11%, 84.72% and 78.33% on four benchmark datasets, respectively. To further validate the performance of the DTIFS, we compare it with other excellent methods and Support Vector Machine (SVM) model. The experimental results of cross-validation indicated that DTIFS is feasible in predicting the relationship among drugs and target, and can provide help for the discovery of new candidate drugs.
Read morePrediction of Drug–Target Interaction Networks from the Integration of Protein Sequences and Drug Chemical Structures
Knowledge of drug–target interaction (DTI) plays an important role in discovering new drug candidates. Unfortunately, there are unavoidable shortcomings; including the time-consuming and expensive nature of the experimental method to predict DTI. Therefore, it motivates us to develop an effective computational method to predict DTI based on protein sequence. In the paper, we proposed a novel computational approach based on protein sequence, namely PDTPS (Predicting Drug Targets with Protein Sequence) to predict DTI. The PDTPS method combines Bi-gram probabilities (BIGP), Position Specific Scoring Matrix (PSSM), and Principal Component Analysis (PCA) with Relevance Vector Machine (RVM). In order to evaluate the prediction capacity of the PDTPS, the experiment was carried out on enzyme, ion channel, GPCR, and nuclear receptor datasets by using five-fold cross-validation tests. The proposed PDTPS method achieved average accuracy of 97.73%, 93.12%, 86.78%, and 87.78% on enzyme, ion channel, GPCR and nuclear receptor datasets, respectively. The experimental results showed that our method has good prediction performance. Furthermore, in order to further evaluate the prediction performance of the proposed PDTPS method, we compared it with the state-of-the-art support vector machine (SVM) classifier on enzyme and ion channel datasets, and other exiting methods on four datasets. The promising comparison results further demonstrate that the efficiency and robust of the proposed PDTPS method. This makes it a useful tool and suitable for predicting DTI, as well as other bioinformatics tasks.
Read moreLink prediction in drug-target interactions network using similarity indices
BackgroundIn silico drug-target interaction (DTI) prediction plays an integral role in drug repositioning: the discovery of new uses for existing drugs. One popular method of drug repositioning is network-based DTI prediction, which uses complex network theory to predict DTIs from a drug-target network. Currently, most network-based DTI prediction is based on machine learning – methods such as Restricted Boltzmann Machines (RBM) or Support Vector Machines (SVM). These methods require additional information about the characteristics of drugs, targets and DTIs, such as chemical structure, genome sequence, binding types, causes of interactions, etc., and do not perform satisfactorily when such information is unavailable. We propose a new, alternative method for DTI prediction that makes use of only network topology information attempting to solve this problem.ResultsWe compare our method for DTI prediction against the well-known RBM approach. We show that when applied to the MATADOR database, our approach based on node neighborhoods yield higher precision for high-ranking predictions than RBM when no information regarding DTI types is available.ConclusionThis demonstrates that approaches purely based on network topology provide a more suitable approach to DTI prediction in the many real-life situations where little or no prior knowledge is available about the characteristics of drugs, targets, or their interactions.
Read moreAn efficient computational method for predicting drug-target interactions using weighted extreme learning machine and speed up robot features
BackgroundPrediction of novel Drug–Target interactions (DTIs) plays an important role in discovering new drug candidates and finding new proteins to target. In consideration of the time-consuming and expensive of experimental methods. Therefore, it is a challenging task that how to develop efficient computational approaches for the accurate predicting potential associations between drug and target.ResultsIn the paper, we proposed a novel computational method called WELM-SURF based on drug fingerprints and protein evolutionary information for identifying DTIs. More specifically, for exploiting protein sequence feature, Position Specific Scoring Matrix (PSSM) is applied to capturing protein evolutionary information and Speed up robot features (SURF) is employed to extract sequence key feature from PSSM. For drug fingerprints, the chemical structure of molecular substructure fingerprints was used to represent drug as feature vector. Take account of the advantage that the Weighted Extreme Learning Machine (WELM) has short training time, good generalization ability, and most importantly ability to efficiently execute classification by optimizing the loss function of weight matrix. Therefore, the WELM classifier is used to carry out classification based on extracted features for predicting DTIs. The performance of the WELM-SURF model was evaluated by experimental validations on enzyme, ion channel, GPCRs and nuclear receptor datasets by using fivefold cross-validation test. The WELM-SURF obtained average accuracies of 93.54, 90.58, 85.43 and 77.45% on enzyme, ion channels, GPCRs and nuclear receptor dataset respectively. We also compared our performance with the Extreme Learning Machine (ELM), the state-of-the-art Support Vector Machine (SVM) on enzyme and ion channels dataset and other exiting methods on four datasets. By comparing with experimental results, the performance of WELM-SURF is significantly better than that of ELM, SVM and other previous methods in the domain.ConclusionThe results demonstrated that the proposed WELM-SURF model is competent for predicting DTIs with high accuracy and robustness. It is anticipated that the WELM-SURF method is a useful computational tool to facilitate widely bioinformatics studies related to DTIs prediction.
Read moreEnsemble Learning Models for Drug Target Interaction Prediction
Drug discovery is a crucial phase before drug development since it is the most essential and distinctive means of testing all medications prior to their medical usage. Other processes in drug discovery include drug target interaction predictions, drug repurposing or repositioning, and drug design. Prediction of drug-target interactions is crucial in these cases. Proteins, enzymes, ion channels, and other components of the human body that aid in the treatment of disease are called targets. The interaction between protein targets in the human body and chemical compounds in medications is known as drug target interaction. In terms of time and money, drug discovery research laboratory experiments are inefficient. Machine learning-based procedures, on the other hand, improved the drug delivery mechanism. However, machine learning-based procedures improved drug discovery and drug target interaction prediction, which aided in the prediction of novel medications and the identification of new uses for current drugs. Different ensemble learning strategies for prediction are compared in this research. Ensemble learning methods are machine learning-based methods that employ numerous independent similar or different models to generate an output or make predictions. Among the several computational methods for predicting drug target interactions, ensemble learning methods are one of the chemogenomic strategies. When compared to single models, Extra Tree and Random Forest are extremely accurate ensemble learning approaches that also give low bias and low variance.
Read moreSGcCA: Deciphering Drug-Target Interactions through an End-to-End Model with Spatial and Channel Reconstruction Convolution and Cross-Efficient-Additive Attention.
Drug-Target Interaction (DTI) prediction is an indispensable process in drug repositioning. Wet-lab experiments for potential DTI identification are reliable but expensive, labor-intensive, and time-consuming. Deep learning demonstrates the superior representation learning capability in the DTI prediction. However, there is still debate about how to accurately learn drug and protein features and further effectively fuse these features. To address the above issues, this work introduces SGcCA, an end-to-end DTI prediction framework by incorporating Spatial and Channel reconstruction Convolution (SCConv), Graph convolutional Network (GCN), and Cross-efficient-additive Attention (CEAA). First, an SCConv module is proposed to encode drug features from their SMILES strings and protein features from their amino acid sequences by reducing spatial and channel redundancies. Next, GCN is employed to encode drug features from their 2D molecular graphs. Subsequently, a CEAA block is devised to fuse the learned drug and protein features. Finally, the fused features are taken as the inputs and all unobserved drug-target pairs are classified through a multilayer perceptron. Using accuracy, F1-score, MCC, AUROC, and AUPRC as evaluation metrics, SGcCA outperformed six popular DTI prediction models (i.e., CPI-GNN, MolTrans, BACPI, CPGL, GIFDTI, and FOTF-CPI) under four different experimental scenarios on four publicly available DTI data sets (Human, C.elegans, BindingDB, and DrugBank), showcasing its better interpretability and generalization ability. Ablation study further underscored the importance of SCConv, CEAA, and GCN. Moreover, visualization of the fused features along with case study and molecular docking outcomes ensured that the predicted DTIs matched closely with the real interactions, further proving the greater performance of SGcCA. As an open-source tool, SGcCA is poised to provide support for drug repositioning. The source codes and data are freely available: https://github.com/plhhnu/SGcCA.
Read more